Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by SQUINTO STEPHEN P, Director. Insider active across 2 companies, notably SpringWorks Therapeutics, Inc.. In total, 3 filings have been recorded. History available since 20 May 2021. The latest transaction was filed on 19 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Stephen P. Squinto is a Board Member at SpringWorks Therapeutics, Inc. He brings significant expertise in the biopharmaceutical field, contributing to the strategic direction of the company. His prior experience in drug development enables him to assess projects and research initiatives. As a board member, Stephen P. Squinto plays a crucial role in overseeing operations and aligning the company's goals with patient needs.